Compare Cronos Group Inc (CRON) vs Huntington Ingalls Industries Inc (HII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Huntington Ingalls Industries Inc — how do they compare? Cronos Group Inc trades at $3.13 (market cap $1.14B), while Huntington Ingalls Industries Inc trades at $326.58 (market cap $12.92B). The key difference: Huntington Ingalls Industries Inc is far larger — about 11.3× Cronos Group Inc's market cap, and Huntington Ingalls Industries Inc pays a 1.68% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | HII | |
|---|---|---|
Market Cap | $1.14B | $12.92B |
Sector | Health | Technology |
52-Week High | $3.27 | $453.73 |
52-Week Low | $2.30 | $265.40 |
Enterprise Value | $341.13M | $15.84B |
Dividend Yield | — | 1.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cronos Group (CRON) trades at $3.125, up 4.17% today. The stock shows a bullish technical signal with strong moving average support. Recent Q2 2026 earnings beat expectations with $0.09 EPS versus $0.01 expected, driven by 58% YoY revenue growth. However, the company posted a net loss of $9.45M in 2025, though margins are improving from prior years.
Outlook is mixed; strong international expansion and product launches support growth, but negative cash flow and intense competition pose risks. Analyst consensus is cautious with 60% hold ratings. The stock offers growth potential but requires monitoring of profitability and cash management.
HII trades at $324.38, down 1.94% on the day, with a bullish technical signal supported by moving averages and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $5.27, exceeding expectations, and secured a $2.2 billion contract for surveillance capabilities (GlobeNewsWire, August 11, 2026). Valuation ratios include a P/E of 19.53 and P/S of 0.98, indicating reasonable pricing relative to earnings and sales.
Outlook remains positive due to contract wins and margin expansion, but risks include dependence on U.S. defense spending and competitive pressures. The consensus price target of $359.67 suggests upside potential, supported by 44% buy ratings from analysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Huntington Ingalls Industries Inc
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →
